Revenue GrowthSustained revenue growth of 22.6% in 2025 indicates durable demand for contract and precision plastics across healthcare and consumer end-markets. Continued top-line expansion supports scale, program wins and reinvestment in tooling and capacity, strengthening long-term competitive position.
Margin ImprovementMaterial gross and net margin expansion signals improving operational efficiency and higher value-add mix (assemblies, engineering services). Wider margins enhance resilience to cost swings, provide more cash for R&D and capex, and support sustainable profitability over a multi-quarter horizon.
Cash GenerationPositive free cash flow and operating cash flow exceeding net income demonstrate improving cash conversion and liquidity. Stronger cash generation enables capex funding, debt reduction, and program investments, reducing refinancing risk and improving balance sheet flexibility over coming quarters.